These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 2091765)

  • 1. Immunosuppression and immunomodulation.
    Goust JM; Stevenson HC; Galbraith RM; Virella G
    Immunol Ser; 1990; 50():481-98. PubMed ID: 2091765
    [No Abstract]   [Full Text] [Related]  

  • 2. Immunosuppression and immunomodulation.
    Goust JM; Stevenson H; Galbraith R; Virella G
    Immunol Ser; 1993; 58():465-80. PubMed ID: 8424989
    [No Abstract]   [Full Text] [Related]  

  • 3. [Immunomodulation therapy for autoimmune diseases. New hope for patients with autoimmune diseases].
    Szegedi G
    Orv Hetil; 2005 Apr; 146(14):635-43. PubMed ID: 15889537
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Immunosuppression by means of antilymphocyte serums in humans].
    Revillard JP
    Nouv Rev Fr Hematol; 1972; 12(2):129-37. PubMed ID: 4264610
    [No Abstract]   [Full Text] [Related]  

  • 5. [Immunosuppression: bioligical bases and usage].
    Wilmanns W
    Internist (Berl); 1975 Oct; 16(10):451-9. PubMed ID: 1107251
    [No Abstract]   [Full Text] [Related]  

  • 6. Immunosuppression or immunostimulation or both?
    James DG
    Minerva Med; 1978 Aug; 69(38):2637-42. PubMed ID: 714262
    [No Abstract]   [Full Text] [Related]  

  • 7. [Immunodepressive methods used in clinical medicine].
    Frei PC
    Rev Med Suisse Romande; 1974 Sep; 94(9):711-21. PubMed ID: 4548210
    [No Abstract]   [Full Text] [Related]  

  • 8. Immunotherapy of autoimmune diseases.
    Bach JF
    Recenti Prog Med; 1988; 79(7-8):343-50. PubMed ID: 3059421
    [No Abstract]   [Full Text] [Related]  

  • 9. [Etiopathogenetic differentiation of inflammatory cardiomyopathy. Immunosuppression and immunomodulation].
    Kühl U; Pauschinger M; Schultheiss HP
    Internist (Berl); 1997 Jun; 38(6):590-601. PubMed ID: 9265004
    [No Abstract]   [Full Text] [Related]  

  • 10. Pidotimod. A new biological response modifier. Introduction.
    Maillard F
    Arzneimittelforschung; 1994 Dec; 44(12A):1399-401. PubMed ID: 7857330
    [No Abstract]   [Full Text] [Related]  

  • 11. [Immune modulation therapy in type I diabetes mellitus].
    Schmeidl R; Teuber J; Paschke R; Schwedes U; Usadel KH
    Fortschr Med; 1986 Dec; 104(45):879-83. PubMed ID: 3542769
    [No Abstract]   [Full Text] [Related]  

  • 12. [Immunologic and pharmacological principles for the use of immunosuppressive drugs in autoimmune diseases].
    Floersheim GL
    Schweiz Med Wochenschr; 1970 Dec; 100(52):2241-7. PubMed ID: 4946978
    [No Abstract]   [Full Text] [Related]  

  • 13. [Implications of the immunologic response to the graft in the design of immunosuppressive treatment for liver transplantation].
    de la Mata M; Barrera P; Montero JL; Fraga E; Briceño J; Pozo JC; Solórzano G
    Gastroenterol Hepatol; 2004 Feb; 27 Suppl 1():52-6. PubMed ID: 15195535
    [No Abstract]   [Full Text] [Related]  

  • 14. [Immunopathogenic aspects and principles of immunomodulation therapy in autoimmune and chronic connective tissue diseases].
    Dobloug JH; Førre O; Mellbye OJ; Refsum SB; Christoffersen T
    Tidsskr Nor Laegeforen; 1983 Apr; 103(10):823-8. PubMed ID: 6879516
    [No Abstract]   [Full Text] [Related]  

  • 15. Editorial overview: Immunomodulation: Striking the right balance: using immunomodulators to target infectious diseases, cancer, and autoimmunity.
    Lavelle EC; McLachlan JB
    Curr Opin Pharmacol; 2018 Aug; 41():vii-ix. PubMed ID: 30139514
    [No Abstract]   [Full Text] [Related]  

  • 16. Immunomodulatory treatment strategies in inflammatory cardiomyopathy: current status and future perspectives.
    Noutsias M; Pauschinger M; Poller WC; Schultheiss HP; Kühl U
    Expert Rev Cardiovasc Ther; 2004 Jan; 2(1):37-51. PubMed ID: 15038412
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunoregulation rather than immunosuppression for prevention and treatment of autoimmune disorders.
    Slavin S
    Transplant Proc; 1996 Dec; 28(6):3021-2. PubMed ID: 8962172
    [No Abstract]   [Full Text] [Related]  

  • 18. [Immunosuppressive therapy].
    Delauche MC
    Rev Infirm; 1984 Jul; 34(13):43-6. PubMed ID: 6570884
    [No Abstract]   [Full Text] [Related]  

  • 19. Commentary on new xenobiotic immunosuppressants for transplantation: Where are we, how did we get here, and where are we going?
    Morris RE
    Clin Transplant; 1993 Feb; 7(1 part 2):138-46. PubMed ID: 10148370
    [No Abstract]   [Full Text] [Related]  

  • 20. [Immunosuppressive drug therapy].
    Elonen E
    Duodecim; 1986; 102(22):1684-9. PubMed ID: 3803258
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.